These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 22491501)
1. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Sorbello A; Jones SC; Carter W; Struble K; Boucher R; Truffa M; Birnkrant D; Gada N; Camilli S; Chan I; Dallas S; Scales T; Kosko R; Thompson E; Goodman J; Francis H; Dal Pan G Clin Infect Dis; 2012 Jul; 55(1):1-7. PubMed ID: 22491501 [TBL] [Abstract][Full Text] [Related]
2. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir. Arya V; Carter WW; Robertson SM Clin Pharmacol Ther; 2010 Nov; 88(5):587-9. PubMed ID: 20959843 [TBL] [Abstract][Full Text] [Related]
3. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010. Yu Y; Garg S; Yu PA; Kim HJ; Patel A; Merlin T; Redd S; Uyeki TM Clin Infect Dis; 2012 Jul; 55(1):8-15. PubMed ID: 22491506 [TBL] [Abstract][Full Text] [Related]
4. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza. Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W; Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722 [TBL] [Abstract][Full Text] [Related]
6. The emergency use authorization of peramivir IV: a view from the manufacturer. Hollister AS; Sheridan WP Clin Pharmacol Ther; 2011 Feb; 89(2):172-4. PubMed ID: 21252934 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of peramivir for influenza treatment. Hata A; Akashi-Ueda R; Takamatsu K; Matsumura T Drug Des Devel Ther; 2014; 8():2017-38. PubMed ID: 25368514 [TBL] [Abstract][Full Text] [Related]
9. Peramivir: another tool for influenza treatment? Jain S; Fry AM Clin Infect Dis; 2011 Mar; 52(6):707-9. PubMed ID: 21367723 [No Abstract] [Full Text] [Related]
10. Peramivir and its use in H1N1 influenza. Castillo R; Holland LE; Boltz DA Drugs Today (Barc); 2010 Jun; 46(6):399-408. PubMed ID: 20571608 [TBL] [Abstract][Full Text] [Related]
11. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09. Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265 [TBL] [Abstract][Full Text] [Related]
12. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults. Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657 [TBL] [Abstract][Full Text] [Related]
13. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors. Komeda T; Ishii S; Itoh Y; Sanekata M; Yoshikawa T; Shimada J J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712 [TBL] [Abstract][Full Text] [Related]
14. Peramivir for the treatment of influenza. Shetty AK; Peek LA Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187 [TBL] [Abstract][Full Text] [Related]
15. Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience. Ison MG; Hollister AS; Sheridan WP Clin Infect Dis; 2013 Jan; 56(1):164. PubMed ID: 22972863 [No Abstract] [Full Text] [Related]
16. Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014). Chan-Tack KM; Kim C; Moruf A; Birnkrant DB Antivir Ther; 2015; 20(5):561-4. PubMed ID: 25667992 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies. Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease. Takamatsu K; Marumo S; Fukui M; Hata A J Microbiol Immunol Infect; 2017 Aug; 50(4):541-544. PubMed ID: 28720319 [TBL] [Abstract][Full Text] [Related]
19. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza. Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636 [TBL] [Abstract][Full Text] [Related]
20. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation. Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]